| Scrape Result | 59 |
|---|---|
| Id | 48,581 |
| Active | 1 |
| Created Epoch | 1,702,488,019 |
| Modified Epoch | 1,752,851,370 |
| Original Ad Id | 0 |
| Collationcount | 1 |
| Collationid | 1,213,653,452,688,975 |
| Enddate | 1,702,368,000 |
| Hasuserreported | 0 |
| Hiddensafetydata | 0 |
| Impressionsindex | 0 |
| Isaaaeligible | 0 |
| Isactive | 1 |
| Isprofilepage | 1 |
| Pageisdeleted | 0 |
| Creation Time | 1,702,331,969 |
| Page Id | 112,411,134,550,324 |
| Page Is Profile Page | 0 |
| Is Reshared | 0 |
| Version | 3 |
| Page Like Count | 156,095 |
| Page Is Deleted | 0 |
| Spend | 0 |
| Startdate | 1,702,281,600 |
| Created | 12/13/23, 11:20 AM |
| Modified | 7/18/25, 10:09 AM |
| Status | active |
| Notes | |
| Adarchiveid | 635483048561698 |
| Currency | |
| Entitytype | person_profile |
| Fevinfo | |
| Gatedtype | eligible |
| Hidedatastatus | NONE |
| Impressionstext | |
| Pageid | 112411134550324 |
| Pageinfo | |
| Pagename | B2i Digital |
| Reachestimate | |
| Reportcount | |
| Ad Creative Id | 120203763046410131 |
| Byline | |
| Caption | b2idigital.com |
| Cta Text | Learn more |
| Dynamic Versions | |
| Effective Authorization Category | NONE |
| Display Format | image |
| Title | |
| Link Description | |
| Link Url | https://b2idigital.com/gri-bio |
| Page Welcome Message | |
| Page Name | B2i Digital |
| Page Profile Picture Url | https://scontent-mia3-1.xx.fbcdn.net/v/t39.35426-6/409159470_7147678021960464_3406112112055588089_n.jpg?stp=dst-jpg_s60x60&_nc_cat=104&ccb=1-7&_nc_sid=c53f8f&_nc_ohc=podQawz-eN0AX8L9hVP&_nc_ht=scontent-mia3-1.xx&oh=00_AfCv-hCxIcZ6djeXLVsi5FZG1gJECGIesdYC5MkUF_IC9g&oe=657EDF05 |
| Page Entity Type | person_profile |
| Instagram Actor Name | David Shapiro |
| Instagram Profile Pic Url | https://scontent-mia3-1.xx.fbcdn.net/v/t39.35426-6/410524968_3626202154304762_7147964914243269867_n.jpg?_nc_cat=101&ccb=1-7&_nc_sid=c53f8f&_nc_ohc=7bRyHd5XfWEAX8eVbaP&_nc_ht=scontent-mia3-1.xx&oh=00_AfAXKkdDkJ4CJieILRY-hgQVo7xg4oXLrGABOMRsGae_UA&oe=657F142B |
| Instagram Url | |
| Instagram Handle | |
| Body | Good news from B2i Digital’s featured company, GRI Bio, Inc. (NASDAQ: GRI). The company announced the start of patient enrollment in their Phase 2a clinical trial evaluating lead drug candidate GRI-0621 for idiopathic pulmonary fibrosis (IPF). <br /> <br /> What this means:<br /> - GRI-0621 advances to testing in IPF patients, an essential next step.<br /> - The 36-patient trial will assess the safety effects of inflammation/scarring.<br /> - Positive data could support larger Phase 3 trials.<br /> - GRI is leveraging an expedited 505(b)(2) pathway to accelerate development.<br /> <br /> Marc Hertz, PhD, the CEO of GRI Bio, commented, “The start of enrollment marks another important step forward for GRI as we continue to execute our clinical development plans for our lead program, GRI-0621. We are pleased to meet this significant milestone and remain focused on the successful execution of this Phase 2a study. With the progress made to date and the start of patient dosing expected imminently, we are poised for an exciting 2024 and look forward to unlocking the potential of GRI-0621 for the treatment of fibrotic indications, starting with IPF.”<br /> <br /> Full Press Release: <a href="https://l.facebook.com/l.php?u=https%3A%2F%2Fgribio.com%2Fgri-bio-commences-patient-enrollment-in-phase-2a-biomarker-study-evaluating-lead-program-gri-0621-for-the-treatment-of-idiopathic-pulmonary-fibrosis-ipf%2F&h=AT1hX_wkxIVBtuWfzmUCHNy4ShUAAN08kB5HQerAKkdmndg5aBfHk_vajSZZG40_JIjUJ-0jFIvBud7ljg0WUA_DzAdE7Qp2ef48oaCoA5LUzJin19_-0sF1O92elom3buf9Ir5vCKKfpOYEwiNpDI2oYSlKsRTHTrL5PCr6" rel="nofollow noreferrer" target="_blank" data-lynx-mode="async">https://gribio.com/gri-bio-commences-patient-enrollment-in-phase-2a-biomarker-study-evaluating-lead-program-gri-0621-for-the-treatment-of-idiopathic-pulmonary-fibrosis-ipf/</a><br /> <br /> The company’s news reflects continued progress for GRI. We look forward to seeing updates when interim data emerges in 1H 2024, and we encourage you to visit GRI Bio's website to learn more about their pioneering pipeline and see the company’s comprehensive B2i profile.<br /> <br /> Featured Company Profile <a href="https://l.facebook.com/l.php?u=https%3A%2F%2Fb2idigital.com%2Fgri-bio&h=AT2M1-DeFxL4uH6f_AynIwzRjovkSjrYL__RrNM6A152zZRQojUttNYCZ8SYiKY9hI46t3ppGgjq4s1uwefueP6qWDjmtmBDyPiSv24xNZRE5bZNBEktJX7Gxxj_ELYA6-oEJ1aOHfwOEUzm2nqIPakS6K0" rel="nofollow noreferrer" target="_blank" data-lynx-mode="asynclazy">https://b2idigital.com/gri-bio</a><br /> <br /> Learn more about GRI’s experienced management team, including Marc Hertz, Vipin Kumar (Chaturvedi), Leanne Kelly, and Albert Agro. |
| Branded Content | |
| Current Page Name | B2i Digital |
| Disclaimer Label | |
| Page Profile Uri | https://facebook.com/b2idigital |
| Root Reshared Post | |
| Cta Type | LEARN_MORE |
| Additional Info | |
| Ec Certificates | |
| Country Iso Code | |
| Instagram Branded Content | |
| Statemediarunlabel |